|

ACP-204 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2/3: 1

Top Sponsors

  • ACADIA Pharmaceuticals Inc.1

Indications

  • Alzheimer's Disease Psychosis1
  • Alzheimer's Disease1

Chandler, Arizona1 trial

ACP-204 in Adults With Alzheimer's Disease Psychosis

Chandler Clinical Trials

Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.